
GoHealth, Inc. Hits New 52-Week Low at $4.61 Amid Declining Performance
2025-09-23 15:51:07GoHealth, Inc. has reached a new 52-week low, reflecting a challenging year with a significant performance decline. The company, classified as a microcap with a market capitalization of USD 79 million, shows signs of financial strain, including a negative debt-equity ratio and waning promoter confidence.
Read MoreIs GoHealth, Inc. technically bullish or bearish?
2025-09-20 20:29:29As of 3 September 2025, the technical trend for GoHealth, Inc. has changed from mildly bearish to bearish. The current stance is bearish with weak strength. Key indicators include bearish signals from the daily moving averages and Bollinger Bands, while the weekly MACD and KST show mildly bullish readings, indicating some divergence. The Dow Theory is bearish on a monthly basis, and there are no significant signals from the RSI or OBV. Over the past year, GoHealth has underperformed significantly, with a return of -48.49% compared to the S&P 500's 17.14%....
Read MoreIs GoHealth, Inc. overvalued or undervalued?
2025-09-20 18:48:46As of 7 August 2025, the valuation grade for GoHealth, Inc. has moved from attractive to risky, indicating a shift in perception regarding its investment potential. Based on the current metrics, the company appears to be overvalued. Key ratios include a P/E ratio of 6, an EV to EBITDA of 0.44, and a PEG ratio of 0.05, all of which suggest that the stock is not priced in line with its earnings growth potential. In comparison to peers, GoHealth's P/E ratio of 2.12 is significantly lower than Crawford & Co.'s fair valuation P/E of 17.88, highlighting a stark contrast in market perception. Additionally, GoHealth's EV to EBITDA ratio of 0.418 is also less favorable compared to its peers. The company's stock has underperformed relative to the S&P 500, with a year-to-date return of -63.7% compared to the index's 12.22%, reinforcing the notion that GoHealth is currently overvalued....
Read More





